Richard Pulik
Director of Finance/CFO at ROIVANT SCIENCES LTD.
Net worth: 3 M $ as of 29/04/2024
Network origin in Richard Pulik first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Pennsylvania
821
| College/University | Other Consumer Services | 821 |
| Public Company | Pharmaceuticals: Major | 27 | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY.
26
| Subsidiary | Pharmaceuticals: Major | 26 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Richard Pulik via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Chief Executive Officer Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin Undergraduate Degree Undergraduate Degree Masters Business Admin Masters Business Admin | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Doctorate Degree Masters Business Admin Doctorate Degree | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chairman Chairman Director/Board Member | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Financial Conglomerates | Analyst-Equity Consultant / Advisor Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree | |
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a private company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The private company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | President Chief Executive Officer Chief Operating Officer | |
| Yale University | College/University | Undergraduate Degree Graduate Degree Masters Business Admin | |
QVT Financial LP
 QVT Financial LP Investment ManagersFinance QVT Financial LP is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded in 2003 by Daniel Gold. QVT Financial provides administrative and/or investment management services to private funds including US limited partnerships, non-US limited partnerships and non-US Corporation. | Investment Managers | Portfolio Manager-Equities Chief Executive Officer Analyst-Equity | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| Roivant Social Ventures, Inc. | Director/Board Member Director/Board Member Director/Board Member | ||
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The private company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Sio Capital Management LLC
 Sio Capital Management LLC Investment ManagersFinance Sio Capital Management LLC (Sio Capital) is an independent registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Dr. Michael Castor in 2006. Sio Capital provides discretionary investment advisory services to domestic and foreign private investment vehicles that are exempt from registration under the Investment Company Act of 1940 and separately managed accounts for institutions and large businesses. | Investment Managers | Analyst-Equity Analyst-Equity | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree | |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal | |
| CAREDX, INC | Medical Specialties | Director/Board Member Director of Finance/CFO | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Masters Business Admin | |
| University of Tokyo | College/University | Undergraduate Degree Undergraduate Degree | |
Fidelity Management & Research Co. LLC
 Fidelity Management & Research Co. LLC Investment ManagersFinance Fidelity Management & Research Co. (FMR) is a SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 1946 and is a subsidiary of FMR LLC, also known as Fidelity Investments. FMR provides investment supervisory services, which include sub-advisory services, to Fidelity's family of mutual funds and exchange-traded funds, qualified tuition programs, privately offered unregistered investment funds, separately managed account clients, and various other institutional accounts. | Investment Managers | Director of Research - Equity Portfolio Manager-Equities | |
| Kellogg School of Management | College/University | Graduate Degree Masters Business Admin | |
Orrick, Herrington & Sutcliffe LLP
 Orrick, Herrington & Sutcliffe LLP Miscellaneous Commercial ServicesCommercial Services Orrick, Herrington & Sutcliffe LLP engages in the provision of legal services. Its practices include: antitrust and competition; banking and finance; capital markets; copyright, trademark and false advertising; cyber, privacy and data innovation; employment law and litigation; energy; financial services litigation; global compliance and regulatory, infrastructure; intellectual property; patents; public finance; real estate; securities litigation; supreme court and appellate; tax advocacy; technology transactions; trials; and white collar, investigations, securities litigation and compliance. The company was founded by John R. Garboe in 1863 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal General Counsel | |
| Yale Law School | College/University | Graduate Degree Graduate Degree | |
Xoc Pharmaceuticals, Inc.
 Xoc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Xoc Pharmaceuticals, Inc. operates as Biopharmaceutical Company. It focuses on the development of innovative therapeutics. The company was founded by Scott W. Borland, Miguel Guzman and Lisa Borland and is headquartered in Los Gatos, CA. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Biotechnology | Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Vion Pharmaceuticals, Inc.
 Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Highbridge Capital Management LLC
 Highbridge Capital Management LLC Investment ManagersFinance Highbridge Capital Management LLC (HCM Highbridge is a registered investment advisor and global alternative investment firm headquartered in New York City. The firm was founded in 1992 and is a subsidiary of JPMorgan Asset Management Holdings Inc., which is a wholly-owned subsidiary of JPMorgan Chase & Co. (NYSE: JPM). Highbridge manages capital for sophisticated investors, who include financial institutions, public and corporate pension funds, sovereign wealth funds, endowments and family offices. | Investment Managers | Corporate Officer/Principal President |
Statistics
International
| United States | 44 |
| United Kingdom | 3 |
| Bermuda | 3 |
| Switzerland | 2 |
| France | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 14 |
| Finance | 10 |
| Commercial Services | 6 |
Operational
| Director/Board Member | 323 |
| Corporate Officer/Principal | 162 |
| Undergraduate Degree | 92 |
| Independent Dir/Board Member | 92 |
| Private Equity Investor | 53 |
Most connected contacts
| Insiders | |
|---|---|
| Pierre Legault | 45 |
| George Bickerstaff | 37 |
| Frank Torti | 35 |
| Clarence Machado | 29 |
| Meghan Fitzgerald | 28 |
| Kenneth Ludlum | 23 |
| Berndt A. E. Modig | 23 |
| Wan Li Zhu | 22 |
| Howard Marks | 20 |
| Atul Pande | 20 |
| Wendell Pritchett | 19 |
| Salvatore Tirabassi | 18 |
| Kathleen Sebelius | 18 |
| Jim Momtazee | 17 |
| Andrew Fromkin | 16 |
- Stock Market
- Insiders
- Richard Pulik
- Company connections
